TrueBlue Reports Q2 2025: Stable Revenue with Reduced Losses Amid Ongoing Market Challenges

TrueBlue, Inc. (NYSE: TBI) recently released its 10-Q report for the quarter ending June 29, 2025. This report highlights critical developments and performances from the company over the period.

Key Financial Metrics:

• Total Revenue: $396.3 million (compared to $396.2 million for the same period last year)
• Net Income (Loss): $(160,000) (loss of $(104.7 million) year-over-year)
• Gross Profit: $93.6 million, representing 23.6% of total revenue (down from 26.4% a year prior)
• SG&A Expenses: $89.8 million, a reduction of 7.4% from the previous year
• Shares Outstanding: 29.9 million as of July 27, 2025
• Cash and Cash Equivalents: $21.9 million
• Debt Outstanding: $53.8 million

Positive Aspects:

• SG&A expenses decreased significantly by 7.4% driven by operational cost management.
• No major goodwill impairment charges this year, compared to $59.7 million last year.
• Revenue remained stable despite a challenging economic landscape, with certain segments, like PeopleSolutions, seeing revenue growth.
• Cash management is robust, with a total liquidity figure of $100.9 million available due to unused portions of the revolving credit facility.

Negative Aspects:

• Gross profit as a percentage of revenue has declined due to changes in revenue mix towards lower-margin businesses.
• The company reported a net loss, although significantly less than the prior year's loss, indicating ongoing challenges.
• Declines in revenues from PeopleReady, attributed to hesitancies in client staffing decisions amid economic uncertainties.
• Impairment charges of $0.2 million for intangible assets, while minor, signal underlying concerns in specific segments.

In summary, while TrueBlue, Inc. shows signs of operational improvement through cost management and stabilization of revenue, challenges remain, particularly in terms of margin pressure and overall demand for staffing solutions. Going forward, the company anticipates revenue growth for the third quarter of 2025, driven partly by the recent acquisition in the healthcare sector.